TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT …
New Gene Expression Analysis from Ongoing Phase 2 Study Provides Strong Biomarker Evidence that Treatment with TFF TAC Results in Normalization of Rejection-Related Genes TFF TAC Prevented Rejection at 1/6 of Oral Tacrolimus Dose and with 2/3 of Oral Tacrolimus Systemic Trough Exposures 4 out of 4…#tacrolimusdose #havechosen #remain #tac #safetyextensionphase #tffpharmaceuticals #tffp #thinfilmfreezingtff #phase2 #tacrolimusinhalation (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2024 Category: Consumer Health News Source Type: news
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis
TUESDAY, March 5, 2024 -- For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2024 Category: Pharmaceuticals Source Type: news
It's Risky to Mix Paxlovid With Immunosuppressants It's Risky to Mix Paxlovid With Immunosuppressants
The EMA has warned that Paxlovid should only be administered alongside tacrolimus, ciclosporin, everolimus, or sirolimus if their blood levels can be closely monitored.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 14, 2024 Category: Allergy & Immunology Tags: Pharmacist Source Type: news
Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging error
Dr Reddy's Laboratories is recalling over 8,000 bottles of Tacrolimus capsules from the US market due to a packaging error. The Hyderabad-based drug major has already recalled 4,000 bottles of the same medication in March 2023. The recall is a Class II recall, initiated on December 15, 2023, due to potential adverse health consequences or a low probability of serious adverse health effects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 7, 2024 Category: Pharmaceuticals Source Type: news
Alternative Antirejection Regimen in Pediatric Heart Transplant Alternative Antirejection Regimen in Pediatric Heart Transplant
Results of the head-to-head TEAMMATE trial show the combination of everolimus and low-dose tacrolimus can be considered an alternative to MMF plus tacrolimus in pediatric heart transplant.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2023 Category: Consumer Health News Tags: Cardiology News Source Type: news
FDA Approval Demonstrates the Role of Real-World Evidence in Regulatory Decision-Making on Drug Effectiveness
FDA recently approved Prograf (tacrolimus) in combination with other immunosuppressant drugs for the new indication of preventing organ rejection in adult and pediatric patients receiving lung transplantation. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 2, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
NLM Technical Bulletin, Sep-Oct 2023, RxNorm October 2023 Monthly Release
The RxNorm October 2023 monthly release became available on Monday, October 2, 2023. We have made changes to Xacduro and some tacrolimus products for this release. (Source: NLM Technical Bulletin)
Source: NLM Technical Bulletin - October 2, 2023 Category: Databases & Libraries Source Type: news
FDA is changing the therapeutic equivalence rating for Accord Healthcare Inc. ’s generics of Prograf (tacrolimus) oral capsules
Based on new data, the U.S. Food and Drug Administration is changing the therapeutic equivalence rating for tacrolimus oral capsule products manufactured by Accord Healthcare Inc. under abbreviated new drug application 091195. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Tacrolimus After Lung Transplant Cuts Chronic Lung Allograft Dysfunction
(MedPage Today) -- MILAN -- Once-a-day tacrolimus significantly reduced chronic lung allograft dysfunction (CLAD) in lung transplant patients compared with the standard immunosuppressant, according to the ScanCLAD trial.
Among patients who underwent... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 11, 2023 Category: Surgery Source Type: news
Meta-Analysis Points to Most Effective Topical Treatments for Atopic Dermatitis
(MedPage Today) -- Pimecrolimus, tacrolimus, and moderate-potency topical corticosteroids (TCS) are the most effective in the treatment of atopic dermatitis (AD), according to a systematic review and meta-analysis.
High-certainty evidence showed... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 8, 2023 Category: Allergy & Immunology Source Type: news
Dr Reddy's Lab recalls over 4,000 bottles of generic drug in US
New Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to "Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules," USFDA said in its latest Enforcement Report. The affected lot was produced at the company's Bachupally-based manufacturing plant and marketed in the US by its American arm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 7, 2023 Category: Pharmaceuticals Source Type: news
Tacrolimus Variability Explored in Peds Kidney Transplant Recipients
THURSDAY, July 28, 2022 -- For pediatric kidney transplant recipients, tacrolimus intrapatient variability is associated with C1q-binding de novo donor-specific antibody formation, according to a study published online July 26 in the Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 28, 2022 Category: Pharmaceuticals Source Type: news
Can You Put Tacrolimus on Genitals?
Title: Can You Put Tacrolimus on Genitals?Category: Diseases and ConditionsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/7/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 7, 2022 Category: Dermatology Source Type: news
Tacrolimus Measures Up in Lupus Nephritis Trial
(MedPage Today) -- In a phase III trial, oral tacrolimus (Prograf) proved non-inferior to intravenous cyclophosphamide for treating lupus nephritis, researchers said.
Among 158 patients randomized to tacrolimus, 83.0% achieved complete or partial... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 30, 2022 Category: Rheumatology Source Type: news
Tacrolimus Tied to Post Liver Transplant Cancer Risk Tacrolimus Tied to Post Liver Transplant Cancer Risk
Higher cumulative exposure to tacrolimus in the first year after liver transplant was linked to a higher risk for de novo malignancies and recurrent liver cancer in a case-control study from Spain.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 23, 2022 Category: Transplant Surgery Tags: Transplantation News Source Type: news
